These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 27061271)

  • 1. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Wu C; Nazi I; Crowther MA
    J Thromb Haemost; 2016 Jun; 14(6):1206-10. PubMed ID: 27061271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
    Farasatinasab M; Zarei B; Moghtadaei M; Nasiripour S; Ansarinejad N; Zarei M
    J Clin Pharmacol; 2020 Oct; 60(10):1362-1366. PubMed ID: 32519800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of the rivaroxaban for heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Crowther MA
    J Thromb Thrombolysis; 2014 Nov; 38(4):485-92. PubMed ID: 24549975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
    Davis KA; Davis DO
    Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
    Cirbus K; Simone P; Austin Szwak J
    J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.
    Warkentin TE; Pai M; Linkins LA
    Blood; 2017 Aug; 130(9):1104-1113. PubMed ID: 28646118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
    Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P
    Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.
    Casan JM; Grigoriadis G; Chan N; Chunilal S
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27520997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.
    Sartori M; Favaretto E; Cini M; Legnani C; Cosmi B
    J Thromb Thrombolysis; 2015 Oct; 40(3):392-4. PubMed ID: 25804370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
    Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.
    Welsby IJ; Krakow EF; Heit JA; Williams EC; Arepally GM; Bar-Yosef S; Kong DF; Martinelli S; Dhakal I; Liu WW; Krischer J; Ortel TL
    J Thromb Haemost; 2017 Jan; 15(1):57-65. PubMed ID: 27714919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
    Snodgrass MN; Shields J; Rai H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia.
    Albuloushi A; Rhoten M; Kelly J; Sylvester KW; Grandoni J; Connors JM
    J Thromb Thrombolysis; 2022 Nov; 54(4):597-604. PubMed ID: 36129561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
    Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
    BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
    Manji F; Warkentin TE; Sheppard JI; Lee A
    Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
    Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
    J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.